Diligence memo · auto-generated · as of July 2, 2026
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. has raised $56M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
BlueSphere Bio, Inc. operates in Biotech / Pharma, based in PITTSBURGH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BlueSphere Bio, Inc. has raised $56M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $46M on 2020-12-18.
Most recent recorded round closed around 2020-12-18.
Valuation (modeled)modeled
Provath models BlueSphere Bio, Inc. at approximately $1.5B (range $145M–$3.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 27 months.
Last raise 5.5 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 4.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 90% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 96% of those peers.
Closest niche peers: Life Biosciences LLC, Imago BioSciences, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.